Fetal DNA Sequencing Potentially Could Reduce Need for Invasive Prenatal Diagnostic Procedures
August 01, 2018
August 01, 2018
WASHINGTON, Aug. 1 -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
Sequencing the fetal DNA that circulates in a pregnant woman's blood holds promise for modern genomic medicine, according to a review article by Diana W. Bianchi, M.D., a senior researcher and institute director at the National Institutes of Health, and her colleague. Fetal DNA sequencing improves the accuracy of prenatal screening tests . . .
Sequencing the fetal DNA that circulates in a pregnant woman's blood holds promise for modern genomic medicine, according to a review article by Diana W. Bianchi, M.D., a senior researcher and institute director at the National Institutes of Health, and her colleague. Fetal DNA sequencing improves the accuracy of prenatal screening tests . . .